Local Tissue Damage Assessed with Statistical Mapping Analysis of Brain Magnetization Transfer Ratio: Relationship with Functional Status of Patients in the Earliest Stage of Multiple Sclerosis

References

1. ↵
   McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–127

   CrossRefPubMedWeb of Science
2. ↵
   Miki Y, Grossman RI, Udupa JK, et al. Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images–lack of correlation between changes in T2 lesion volume and clinical findings. Radiology 1999;213:395–399

   CrossRefPubMedWeb of Science
3. ↵
   Nijeholt GJ, van Walderveen MA, Castelijns JA, et al. Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998;121:687–697

   Abstract/FREE Full Text
4. ↵
   Reddy H, Narayanan S, Arnoutelis R, et al. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Brain 2000;123:2314–2320

   Abstract/FREE Full Text
5. ↵
   Filippi M, Rocca MA, Falini A, et al. Correlations between structural CNS damage and functional MRI changes in primary progressive MS. Neuroimage 2002;15:537–546

   CrossRefPubMedWeb of Science
6. ↵
   Rocca MA, Mezzapesa DM, Falini A, et al. Evidence for axonal pathology and adaptive cortical reorganization in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage 2003;18:847–855

   CrossRefPubMedWeb of Science
7. ↵
   Audoin B, Ibarrola D, Ranjeva J, et al. Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Hum Brain Mapp 2003;20:51–58

   CrossRefPubMedWeb of Science
8. ↵
   Rovaris M, Agosta F, Sormani MP, et al. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study. Brain 2003;126:2323–2332

   Abstract/FREE Full Text
9. ↵
   Kalkers NF, Hintzen RQ, van Waesberghe JH, et al. Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy. J Neurol Sci 2001;184:155–162

   CrossRefPubMedWeb of Science
10. ↵
    Charil A, Zijdenbos AP, Taylor J, et al. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 2003;19:532–544

    CrossRefPubMedWeb of Science
11. ↵
    Sailer M, Fischl B, Salat D, et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 2003;126:1734–1744

    Abstract/FREE Full Text
12. ↵
    Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444–1452

    Abstract/FREE Full Text
13. ↵
    Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122:871–882

    Abstract/FREE Full Text
14. ↵
    Fischer JS, Rudick RA, Cutter GR, et al. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999;5:244–250

    Abstract/FREE Full Text
15. ↵
    Ashburner J, Friston K. Voxel-based morphometry: the methods. Neuroimage 2000;11:805–821

    CrossRefPubMedWeb of Science
16. ↵
    Good CD, Johnsrude IS, Ashburner J, et al. A voxel-based morphometric study of aging in 465 normal adult human brains. Neuroimage 2001;14:21–36

    CrossRefPubMedWeb of Science
17. ↵
    Friston KJ, Holmes AP, Poline JB, et al. Analysis of fMRI time-series revisited. Neuroimage 1995;2:45–53

    CrossRefPubMedWeb of Science
18. ↵
    Friston KJ, Holmes AP, Price CJ, et al. Multisubject fMRI studies and conjunction analyses. Neuroimage 1999;10:385–396

    CrossRefPubMedWeb of Science
19. ↵
    Rugg-Gunn FJ, Eriksson SH, Boulby PA, et al. Magnetization transfer imaging in focal epilepsy. Neurology 2003;60:1638–1645

    Abstract/FREE Full Text
20. ↵
    Tortorella C, Viti B, Bozzali M, et al. A magnetization transfer histogram study of normal-appearing brain tissue in MS. Neurology 2000;54:186–193

    Abstract/FREE Full Text
21. Evangelou N, Esiri MM, Smith S, et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000;47:391–395

    CrossRefPubMedWeb of Science
22. Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81–91

    CrossRefPubMedWeb of Science
23. ↵
    De Stefano N, Matthews P, Filippi M, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003;60:1157–1162

    Abstract/FREE Full Text
24. ↵
    Chard DT, Griffin CM, Barker GJ, et al. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125:327–337

    Abstract/FREE Full Text
25. ↵
    Traboulsee A, Dehmeshki J, Brex PA, et al. Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS. Neurology 2002;59:126–128

    Abstract/FREE Full Text
26. ↵
    Iannucci G, Tortorella C, Rovaris M, et al. Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. AJNR Am J Neuroradiol 2000;21:1034–1038

    Abstract/FREE Full Text
27. ↵
    Ranjeva JP, Pelletier J, Confort-Gouny S, et al. MRI/MRS of corpus callosum in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2003;9:554–565

    Abstract/FREE Full Text
28. ↵
    Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. New York: Thieme Medical Publishers, Inc.,1988
29. ↵
    Kidd D, Barkhof F, McConnell R, et al. Cortical lesions in multiple sclerosis. Brain 1999;122:17–26

    Abstract/FREE Full Text
30. Peterson J, Bo L, Mork S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389–400

    CrossRefPubMedWeb of Science
31. ↵
    Bo L, Vedeler CA, Nyland HI, et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003;62:723–732

    PubMedWeb of Science
32. ↵
    Cifelli A, Arridge M, Jezzard P, et al. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52:650–653

    CrossRefPubMedWeb of Science
33. ↵
    Quarantelli M, Ciarmiello A, Morra VB, et al. Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. Neuroimage 2003;18:360–366

    CrossRefPubMedWeb of Science
34. ↵
    Filippi M, Bozzali M, Rovaris M, et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 2003;126:433–437

    Abstract/FREE Full Text
35. ↵
    Neumann H. Molecular mechanisms of axonal damage in inflammatory central nervous system diseases. Curr Opin Neurol 2003;16:267–273

    CrossRefPubMedWeb of Science
36. ↵
    Wylezinska M, Cifelli A, Jezzard P, et al. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 2003;60:1949–1954

    Abstract/FREE Full Text
37. ↵
    Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962;25:315–320
38. ↵
    Lumsden C. The Neuropathology of Multiple Sclerosis. Amsterdam: North-Holland,1970
39. ↵
    Matthews P, Pioro E, Narayanan S, et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 1996;119:715–722

    Abstract/FREE Full Text
40. De Stefano N, Matthews PM, Fu L, et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: results of a longitudinal magnetic resonance spectroscopy study. Brain 1998;121:1469–1477

    Abstract/FREE Full Text
41. ↵
    Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278–285

    CrossRefPubMedWeb of Science
42. ↵
    Alexander G, Crutcher M. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:166–171
43. ↵
    Corrigan JD, Hinkeldey NS. Relationships between parts A and B of the Trail Making Test. J Clin Psychol 1987;43:402–409

    CrossRefPubMedWeb of Science
44. ↵
    Goldstein G, Shelly CH. Statistical and normative studies of the Halstead Neuropsychological Test Battery relevant to a neuropsychiatric hospital setting. Percept Mot Skills 1972;34:603–620

    CrossRefPubMedWeb of Science
45. ↵
    Swiercinsky DP. Factorial pattern description and comparison of functional abilities in neuropsychological assessment. Percept Mot Skills 1979;48:231–241

    PubMed
46. ↵
    Baars BJ. The conscious access hypothesis: origins and recent evidence. Trends Cogn Sci 2002;6:47–52

    CrossRefPubMedWeb of Science